NewsRx

Search our medical news database

Leukemia

Findings from University of Alabama provide new insights into leukemia

Published in TB and Outbreaks Week, November 30th, 2010

2010 NOV 30 -- "Aspergillus species are ubiquitous and exposure to this fungus is frequent, yet disease due to tissue invasion is uncommon in the immunocompetent host," scientists writing in the Journal of Oral and Maxillofacial Surgery report.

"However, in the immunocompromised patient, there is an increased incidence of invasive aspergillosis.' Patients with acute leukemia are particularly susceptible to invasive aspergillosis, with the lungs being the most common site. The major predisposing factor seems to be the associated chemotherapy-induced granulocytopenia.(2) Although pulmonary invasive aspergillosis is most common, other anatomical sites...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook